Item 1: Financial Statements DLT RESOLUTION, INC | | Condensed Consolidated Balance Sheets | | (Unaudited) | | | | | | | | March 31, 2020 | | | December 31, 2019 | | ASSETS | | Current assets | | | | | | | Cash and cash equivalents | | $ | - | | | $ | 13,140 | | Accounts receivable, net of allowance for doubtful accounts of $44,730 at March 31, 2020 and $0 at December 31, 2019 | | | 171,396 | | | | 34,631 | | Total current assets | | | 171,396 | | | | 47,771 | | | | | | | | | | | Property, plant and equipment, net of accumulated depreciation | | | 84,869 | | | | - | | Operating lease – right of use asset | | | 11,642 | | | | - | | Intangible assets, net of accumulated amortization | | | 4,142,409 | | | | 376,460 | | Goodwill | | | - | | | | 165,022 | | | | | | | | | | | Total assets | | $ | 4,410,316 | | | $ | 589,253 | | | | | | | | | | | LIABILITIES AND STOCKHOLDERS'DEFICIT | | | | | | | | | | Current liabilities | | | | | | | | | Bank overdraft | | $ | 25,139 | | | $ | 16,782 | | Accounts payable and accrued liabilities | | | 471,702 | | | | 99,201 | | Accounts payable, related party | | | 15,000 | | | | 15,000 | | Interest payable, related party | | | 36,034 | | | | 34,190 | | Related party payables | | | 20,858 | | | | 20,880 | | Note payable, related party | | | 81,500 | | | | 81,500 | | Lease obligation – operating lease | | | 6,023 | | | | - | | Total current liabilities | | | 656,256 | | | | 267,553 | | | | | | | | | | | Notes payable, net of current portion | | | 5,000 | | | | 5,000 | | Other long term liability | | | 2,001,461 | | | | 685,000 | | Lease obligation – operating lease, net of current portion | | | 5,128 | | | | - | | Total liabilities | | | 2,667,845 | | | | 957,553 | | | | | | | | | | | Stockholders' deficit | | | | | | | | | Series A convertible preferred stock, $1.00 par value; 5,000,000 shares authorized; 0 and 25,000 issued and outstanding at March 31, 2020 and December 31, 2019 | | | - | | | | - | | Series B convertible preferred stock, $1.00 par value; 500,000 shares authorized; 64,000 and 64,000 issued and outstanding at March 31, 2020 and December 31, 2019 | | | 64,000 | | | | 64,000 | | Common stock, $0.001 par value; 275,000,000 shares authorized; 25,926,287 and 24,395,037 issued; 22,698,787 and 21,167,537 outstanding at March 31, 2020 and December 31, 2019 | | | 25,926 | | | | 24,395 | | Additional paid-in capital | | | 6,641,734 | | | | 4,218,265 | | Other comprehensive income | | | (19,757 | ) | | | (34,430 | ) | Treasury stock, 3,815,000 shares as of March 31, 2020 and December 31, 2019, at cost | | | (5,300 | ) | | | (5,300 | ) | Accumulated deficit | | | (4,964,132 | ) | | | (4,653,230 | ) | Total stockholders’ deficit | | | 1,742,471 | | | | (368,300 | ) | | | | | | | | | | Total liabilities and stockholders' deficit | | $ | 4,410,316 | | | $ | 589,253 | | | | | | | | | | | See accompanying notes to condensed consolidated financial statements. |
Item 1: Financial Statements
DLT RESOLUTION, INC. | | Condensed Consolidated Statements of Operations | | (Unaudited) | | | | | | | | | | | Three months ended March 31, | | | | 2020 | | | 2019 | | | | | | | | | Revenue | | | 428,347 | | | $ | 122,009 | | | | | | | | | | | Cost of revenue and operating expenses | | | | | | | | | Cost of revenue | | | 238,686 | | | | 33,674 | | General and administrative | | | 196,245 | | | | 59,354 | | Depreciation and amortization | | | 115,268 | | | | 25,655 | | Professional fees | | | 40,439 | | | | 32,571 | | Goodwill impairment loss | | | 159,187 | | | | - | | Total operating expenses | | | 749,825 | | | | 117,580 | | | | | | | | | | | Loss from operations | | | (321,478 | ) | | | (29,245 | ) | | | | | | | | | | Other income (expense) | | | | | | | | | Loss on stock based liability | | | - | | | | (526,571 | ) | Foreign exchange gain | | | - | | | | 5,366 | | Loss on investment | | | - | | | | (331,787 | ) | Interest expense | | | (7,424 | ) | | | (1,804 | ) | Total other (expense) | | | (7,424 | ) | | | (854,796 | ) | | | | | | | | | | Net loss | | | (328,902 | ) | | $ | (884,041 | ) | | | | | | | | | | Basic loss per common share - net loss | | | (0.01 | ) | | $ | (0.05 | ) | Diluted loss per common share - net loss | | | (0.01 | ) | | $ | (0.05 | ) | Weighted average basic shares outstanding | | | 25,427,317 | | | | 19,263,408 | | Weighted average diluted shares outstanding | | | 25,427,317 | | | | 19,263,408 | | | | | | | | | | | See accompanying notes to condensed consolidated financial statements. |
HEMCARE HEALTH SERVICES INC. | Balance Sheets | (Unaudited) | | | | | | | September 30, 2017 | | | December 31, 2016 | | ASSETS | | Intangible assets | | $ | 55,000 | | | $ | - | | | | | | | | | | | Total assets | | $ | 55,000 | | | $ | - | | | | | | | | | | | LIABILITIES AND STOCKHOLDERS' DEFICIT | | | | | | | | | | Current liabilities | | | | | | | | | Bank overdraft | | $ | 7 | | | $ | 7 | | Accounts payable and accrued liabilities | | | 106,656 | | | | 38,772 | | Dividends payable | | | 25,448 | | | | 25,448 | | Related party payables | | | 49,544 | | | | 39,599 | | Current notes payables | | | 81,500 | | | | 332,100 | | Derivative liability | | | 68,793 | | | | - | | Convertible notes payable, net of discounts of $0 and $6,916 | | | 4,900 | | | | 23,784 | | Related party convertible notes payable, net of discounts $0 and $0 | | | - | | | | 2,634 | | Total current liabilities | | | 336,848 | | | | 462,344 | | | | | | | | | | | Related party notes payable, net of current portion | | | 10,000 | | | | - | | Notes payable, net of current portion | | | 85,000 | | | | - | | | | | | | | | | | Total liabilities | | | 431,848 | | | | 462,344 | | | | | | | | | | | Stockholders' deficit | | | | | | | | | Series A convertible preferred stock, $1.00 par value; 5,000,000 shares authorized, 25,000 and 0 issued and outstanding at September 30, 2017 and December 31, 2016 | | | 25,000 | | | | - | | Common stock, $0.001 par value; 275,000,000 shares authorized; 212,275,211 and 273,332,211 issued; 123,225,211 and 272,952,211 outstanding at September 30, 2017 and December 31, 2016 | | | 212,275 | | | | 273,332 | | Additional paid in capital | | | 2,902,463 | | | | 2,613,165 | | Other comprehensive income | | | 24 | | | | 24 | | Treasury stock, 89,050,000 shares | | | (95,200 | ) | | | (100 | ) | Accumulated deficit | | | (3,421,410 | ) | | | (3,348,765 | ) | Total stockholders' deficit | | | (376,848 | ) | | | (462,344 | ) | | | | | | | | | | Total liabilities and stockholders' deficit | | $ | 55,000 | | | $ | - | |
See accompanying notes to unaudited financial statements.
HEMCARE HEALTH SERVICES INC. | Statements of Operations | (Unaudited) | | | | | | | | | | | | | | | | Three months ended September 30, | | | Nine months ended September 30, | | | | 2017 | | | 2016 | | | 2017 | | | 2016 | | Revenue | | $ | - | | | $ | - | | | $ | - | | | $ | - | | | | | | | | | | | | | | | | | | | Operating expenses | | | | | | | | | | | | | | | | | General and administrative | | | 579 | | | | 1,162 | | | | 6,419 | | | | 8,320 | | Professional fees | | | 3,121 | | | | 1,228 | | | | 14,879 | | | | 17,116 | | Total operating expenses | | | 3,700 | | | | 2,390 | | | | 21,298 | | | | 25,436 | | | | | | | | | | | | | | | | | | | Other income (expense) | | | | | | | | | | | | | | | | | Discharge of indebtedness | | | - | | | | - | | | | 26,306 | | | | - | | Loss on change in fair market value of derivative liability | | | (63,886 | ) | | | - | | | | (63,445 | ) | | | - | | Interest expense | | | (5,218 | ) | | | (7,994 | ) | | | (14,208 | ) | | | (44,525 | ) | Total other income (expense) | | | (69,104 | ) | | | (7,994 | ) | | | (51,347 | ) | | | (44,525 | ) | | | | | | | | | | | | | | | | | | Net income (loss) | | $ | (72,804 | ) | | $ | (10,384 | ) | | $ | (72,645 | ) | | $ | (69,961 | ) | | | | | | | | | | | | | | | | | | Preferred stock dividends declared | | | - | | | | (1,591 | ) | | | - | | | | (6,448 | ) | Net income (loss) attributable to common shareholders | | $ | (72,804 | ) | | $ | (11,975 | ) | | $ | (72,645 | ) | | $ | (76,409 | ) | | | | | | | | | | | | | | | | | | Basic and diluted loss per common share | | $ | (0.00 | ) | | $ | (0.00 | ) | | $ | (0.00 | ) | | $ | (0.00 | ) | | | | | | | | | | | | | | | | | | Weighted average shares outstanding - basic | | | 153,917,570 | | | | 190,258,081 | | | | 200,403,394 | | | | 158,118,401 | |
See accompanying notes to unaudited financial statements.
DLT RESOLUTION, INC. | | Condensed Consolidated Statements of Comprehensive Loss | | | | | | | | | | | Three months ended March 31, | | | | 2020 | | | 2019 | | | | | | | | | Net loss | | | (328,902 | ) | | $ | (884,041 | ) | | | | | | | | | | Other comprehensive income | | | | | | | | | Gain on adjusted value of other long-term liability | | | 230,024 | | | | - | | Foreign currency translation adjustment | | | (215,351 | ) | | | 30,776 | | Total other comprehensive income | | | 14,673 | | | | 30,776 | | | | | | | | | | | Comprehensive loss | | | (314,229 | ) | | $ | (853,265 | ) | | | | | | | | | | See accompanying notes to condensed consolidated financial statements. |
DLT RESOLUTION, INC Condensed Consolidated Statements of Changes in Stockholders' Deficit HEMCARE HEALTH SERVICES INC. | Statements of Cash Flows | (Unaudited) | | | | | | | | | | Nine months ended September 30, | | | | 2017 | | | 2016 | | Cash flows from operating activities | | | | | | | Net loss from operations | | $ | (72,645 | ) | | $ | (69,961 | ) | Adjustments to reconcile net loss to net cash used in operating activities | | | | | | | | | Forgiveness of debt | | | (26,306 | ) | | | - | | Amortization of debt discounts | | | 4,900 | | | | 28,508 | | Loss on change in fair market value of derivative liability | | | 63,445 | | | | - | | Excess fair market value of derivative liability charged to interest | | | 448 | | | | - | | Expenses paid on behalf of the company by related parties | | | 6,420 | | | | - | | Changes in operating assets and liabilities | | | | | | | | | Prepaid expenses | | | - | | | | 2,252 | | Accounts payable and accrued liabilities | | | 23,738 | | | | 12,260 | | Net cash used in operating activities | | | - | | | | (26,941 | ) | | | | | | | | | | Net cash used in investing activities | | | - | | | | - | | | | | | | | | | | Cash flows from financing activities | | | | | | | | | Proceeds from bank overdraft | | | - | | | | 7 | | Repayments of related party convertible note payable | | | - | | | | (8,000 | ) | Proceeds from convertible notes payable | | | - | | | | 17,100 | | Repayments of convertible note payable | | | - | | | | (2,500 | ) | Net cash used in financing activities | | | - | | | | 6,607 | | | | | | | | | | | Net change in cash | | | - | | | | (20,334 | ) | Cash at beginning of period | | | - | | | | 20,334 | | Cash at end of period | | $ | - | | | $ | - | | | | | | | | | | | Supplemental cash flow information | | | | | | | | | Cash paid for interest | | $ | - | | | $ | - | | Cash paid for income taxes | | $ | - | | | $ | - | | | | | | | | | | | Non-cash investing and financing activities | | | | | | | | | Forgiveness of related party convertible note payable | | $ | 2,634 | | | $ | - | | Forgiveness of related party interest payable | | $ | 606 | | | $ | - | | Forgiveness of convertible note payable | | $ | 23,783 | | | $ | - | | Forgiveness of note payable | | $ | 600 | | | $ | - | | Forgiveness of interest payable | | $ | 1,923 | | | $ | - | | Common shares issued in exchange for note payable principal | | $ | 250,000 | | | $ | - | | Account payable entered into for intangible asset | | $ | 55,000 | | | $ | - | | Accounts payable paid by related party | | $ | 3,425 | | | $ | - | | Accounts payable paid by convertible noteholder | | $ | 4,900 | | | $ | - | | Related party note payable entered into for purchase of treasury stock | | $ | 10,000 | | | $ | - | | Notes payable entered into for purchase of treasury stock | | $ | 85,000 | | | $ | - | | Related party advance for purchase of treasury stock | | $ | 100 | | | $ | - | | Preferred dividend declared | | $ | - | | | $ | 6,448 | | Preferred stock issued for repayment of note payable | | $ | - | | | $ | 18,500 | | Preferred stock issued for repayment of accrued interest payable | | $ | - | | | $ | 31,500 | |
Three Months Ended March 31, 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Series B Preferred Stock | | | Common Stock | | | Additional Paid-in | | | Treasury | | | Other Comprehensive | | | Accumulated | | | Non-Controlling | | | | | | | Shares | | | Amount | | | Shares | | | Amount | | | Capital | | | Stock | | | income | | | Deficit | | | Interest | | | Total | | Balance, December 31, 2019 | | | 64,000 | | | $ | 64,000 | | | | 24,395,037 | | | $ | 24,395 | | | $ | 4,218,265 | | | $ | (5,300 | ) | | $ | (34,430 | ) | | $ | (4,635,230 | ) | | | - | | | | (368,300 | ) | | | | - | | | | - | | | | | | | | | | | | | | | | | | | | | | | | | | | | - | | | | - | | Issuance of common stock for cash proceeds | | | - | | | | - | | | | 31,250 | | | | 31 | | | | 24,969 | | | | - | | | | - | | | | - | | | | - | | | | 25,000 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - | | | | - | | | | | | Issuance of common stock for acquisitions | | | - | | | | - | | | | 1,500,000 | | | | 1,500 | | | | 2,398,500 | | | | - | | | | - | | | | - | | | | - | | | | 2,400,000 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Foreign currency translation adjustment | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | | (215,351 | ) | | | - | | | | - | | | | (215,351 | ) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gain on adjusted value of other long-term liability | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | | 230,024 | | | | - | | | | - | | | | 230,024 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net loss | | | - | | | | - | | | | - | | | | - | | | | - | | | | | | | | - | | | | (328,902 | ) | | | - | | | | (328,902 | ) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance, March 31, 2020 | | | 64,000 | | | $ | 64,000 | | | | 25,926,287 | | | $ | 25,926 | | | $ | 6,641,734 | | | $ | (5,300 | ) | | $ | (19,757 | ) | | $ | (4,964,132 | ) | | | - | | | $ | 1,742,471 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance, December 31, 2018 | | | 64,000 | | | $ | 64,000 | | | | 24,982,537 | | | $ | 24,983 | | | $ | 4,192,678 | | | $ | (37,688 | ) | | $ | (5,300 | ) | | $ | (3,595,912 | ) | | $ | 94,087 | | | $ | 736,848 | | Foreign currency translation adjustment | | | - | | | | - | | | | - | | | | - | | | | - | | | | 30,775 | | | | - | | | | - | | | | - | | | | 30,775 | | Net loss | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | | (884,041 | ) | | | (94,087 | ) | | | (978,128 | ) | Balance, March 31, 2019 | | | 64,000 | | | $ | 64,000 | | | | 24,982,537 | | | $ | 24,983 | | | $ | 4,192,678 | | | $ | (6,913 | ) | | $ | (5,300 | ) | | $ | (4,479,953 | ) | | $ | - | | | $ | (210,505 | ) |
See accompanying notes to unauditedcondensed consolidated financial statements. DLT RESOLUTION, INC | Condensed Consolidated Statements of Cash Flows | | | | Three Months Ended March 31, 2020 | | | Three Months Ended March 31, 2019 | | | | | | | Cash flows from operating activities | | | | | Net loss | | $ | (328.902 | ) | | $ | (884,041 | ) | Adjustments to reconcile net loss to net cash used in operating activities | | | | | | | | | Loss on investment | | | - | | | | 331,787 | | Loss on stock based liability | | | - | | | | 526,571 | | Loss related items | | | - | | | | (50,581 | ) | Depreciation and amortization expense | | | 115,268 | | | | 25,655 | | Goodwill impairment loss | | | 159,187 | | | | - | | Changes in operating assets and liabilities | | | | | | | | | Accounts receivable | | | 13,958 | | | | (40,509 | ) | Lease obligation | | | (1,580 | ) | | | - | | Interest payable, related party | | | 1,844 | | | | 1,804 | | Accounts payable and accrued liabilities | | | 20,698 | | | | 1,335 | | Accounts payable, related party | | | - | | | | (25,000 | ) | Net cash used in operating activities | | | (19,527 | ) | | | (112,979 | ) | | | | | | | | | | Net cash used in investing activities | | | | | | | | | Purchase of equipment | | | (1,911 | ) | | | - | | Net cash used in investing activities | | | (1,911 | ) | | | - | | | | | | | | | | | Cash flows from financing activities | | | | | | | | | Repayment of bank overdrafts | | | (11,278 | ) | | | - | | Proceeds from sale of common stock | | | 25,000 | | | | | | Proceeds from (repayments to) related parties | | | (4,256 | ) | | | 146,407 | | Net cash provided by financing activities | | | 9,466 | | | | 146,507 | | | | | | | | | | | Net change in cash | | | (11,972 | ) | | | 33,428 | | Effect of exchange rate on cash | | | (1,168 | ) | | | 7,994 | | Cash at beginning of period | | | 13,140 | | | | 12,908 | | Cash at end of period | | $ | - | | | $ | 54,330 | | | | | | | | | | | Supplemental cash flow information | | | | | | | | | Cash paid for interest | | $ | - | | | $ | - | | Cash paid for income taxes | | $ | - | | | $ | - | | | | | | | | | | | Non-cash investing and financing activities | | | | | | | | | Other long term liability entered into for acquisition of Union Strategies, Inc. | | $ | 1,370,000 | | | $ | - | | Common shares issued for acquisition of Union Strategies, Inc. | | $ | 2,400,000 | | | $ | - | | Net of Union Strategies, Inc. assets acquired and liabilities assumed | | $ | 4,000,000 | | | $ | - | | | | | | | | | | | See accompanying notes to condensed consolidated financial statements. |
DLT RESOLUTION, INC. HEMCARE HEALTH SERVICES INC.
Notes to Unaudited Condensed Consolidated Financial Statements September 30, 2017March 31, 2020
Note 1 - Basis of Presentation– Organization and Significant Accounting Policies The accompanying unaudited interim financial statements of Hemcare Health ServicesDLT Resolution Inc. (formerly NSU Resources, Inc.) (collectively referred to herein as “Hemcare Health Services”, “Hemcare”, or(“DLT, the “Company”), have been prepared“we” and “our”) operates in accordance with accounting principles generally acceptedthree high-tech industry segments: Blockchain Applications; Telecommunications; and Data Services which includes Image Capture, Data Collection, Data Phone Center Services, and Payment Processing. The Company offers secure data management, Information Technology (IT) and other telecommunications services in Canada and the United StatesStates. The Company operates a Health Information Exchange providing the ability to request and retrieve medical information and records while meeting all of Americatoday’s Security & Compliance demands for HIPAA, PIPEDA and PHIPA. Through our acquisition of Union Strategies, Inc. (“USI”), the rulesCompany operates a business focused on designing, installing and maintaining telephony, data, video, storage, and LAN/WAN networks. USI’s clients encompass K-12 and higher education institutions, trades industry organizations, and local government entities having memberships ranging from 100 to 10,000 people that utilize products and services that USI provides by deploying a variety of the Securitiestechnologies to keep client networks up and Exchange Commission, and should be read in conjunction with the audited financial statements for the period ended December 31, 2016 and notes thereto contained in the Company’s Form 10-K filed with the SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2016 as reported in the form 10-K have been omitted.
Note 2 - Going Concernrunning efficiently.
The Company had an accumulated deficit of $3,421,410$4,653,230 and a working capital deficit of $336,848$219,782 as of September 30, 2017 and had no revenues.December 31, 2019. These matters raise substantial doubt about the Company’s ability to continue as a going concern. Continuation of the Company’s existence depends upon its ability to obtain additional capital. Management’s plans in regards to this matter include raising additional equity financing and borrowing funds under a private credit facility and/or other credit sources. These unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Note 3 - Significant Accounting PoliciesThe accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and in conformity with the instructions to Form 10-Q and Article 8 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and note disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures included in these condensed consolidated financial statements are adequate to make the information presented not misleading. The unaudited condensed consolidated financial statements included in this document have been prepared on the same basis as the annual consolidated financial statements, and in our opinion reflect all adjustments, which include normal recurring adjustments necessary for a fair presentation in accordance with US GAAP and SEC regulations for interim financial statements. The results for the three months ended March 31, 2020 are not necessarily indicative of the results that we will have for any subsequent period.
Interim Condensed Consolidated Financial Statements The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and in conformity with the instructions to Form 10-Q and Article 8 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and note disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures included in these condensed consolidated financial statements are adequate to make the information presented not misleading. The unaudited condensed consolidated financial statements included in this document have been prepared on the same basis as the annual consolidated financial statements, and in our opinion reflect all adjustments, which include normal recurring adjustments necessary for a fair presentation in accordance with US GAAP and SEC regulations for interim financial statements. The results for the three months ended March 31, 2020 are not necessarily indicative of the results that we will have for any subsequent period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes to those statements for the year ended December 31, 2019 included in our Annual Report on Form 10-K as filed with the SEC on April 30, 2020. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities disclosuresand disclosure of contingent assets and liabilities as ofat the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from thesethose estimates. Cash EquivalentsIncome taxes
The Company considers all highly liquid investments with maturities of three months or less atIncome taxes are provided for using the time of purchase to be cash equivalents.
Prior Period Conformity
The Company has reclassified balances in the prior period financial statements for conformity with the current period for comparison purposes.
Income Taxes
The Company accounts for income taxes under the asset and liability method whereof accounting in accordance with FASB ASC Topic 740 (formally SFAS No. 109 “Accounting for Income Taxes”). A deferred tax assetsasset or liability is recorded for all temporary differences between financial and liabilitiestax reporting. Temporary differences are recognized for the future tax consequences attributable to differences between the financial statements carryingreported amounts of existing assets and liabilities and their respective tax bases.basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are measured using enactedadjusted for the effect of changes in tax laws and rates expected to apply to taxable income inon the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.date of enactment.
At September 30, 2017,March 31, 2020, there were no uncertain tax positions that require accrual. Revenue Recognition The Company follows ASC 606 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue upon the transfer of promised services to customers in amounts that reflect the consideration to which the Company expects to be entitled the transfer of services. The Company considers revenue earned when all the following criteria are met: (i) the contract with the customer has been identified, (ii) the performance obligations have been identified, (iii) the transaction price has been determined, (iv) the transaction price has been allocated to the performance obligations, and (v) the performance obligations have been satisfied. The Company primarily generates revenues through the sale of products through its website and at industry tradeshows. HEMCARE HEALTH SERVICES INC.
Notes to Unaudited Financial Statements
September 30, 2017
Note 3 - Significant Accounting Policies (continued)
Intangible Asset
During the nine months ended September 30, 2017, the Company entered into an agreement whereby a third party would build a web portal as part of executing our business plan. Through September 30, 2017, we had incurred $55,000 of costs to build the portal which are included in accounts payable as of September 30. The portal has yet to be launched and as such there has been no amortization recorded or impairment as of September 30, 2017.
Net Income (Loss) Per Share Net loss per share is calculated in accordance with FASB ASC topic 260. Basic lossearnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Asperiod, assuming conversion or exercise of September 30, 2017, there was a convertible noteall potentially dilutive securities outstanding that could convert to a totalduring each reporting period presented. Potentially dilutive securities are not presented or used in the computation of 490,000 common shares. Because of the net loss incurred during the three and nine months ended September 30, 2017, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded fromdiluted loss per share calculations. Thereon the statement of operations for periods when the Company incurs net losses, as their effect would be anti-dilutive. As of March 31, 2020 and 2019, the Company had 64,000 shares of Series B Convertible Preferred Stock issued and outstanding, which were no potentially dilutive instruments outstanding at September 30, 2016.convertible into 12,800 shares of the Company’s common stock. As of March 31, 2020, the Company expects to issue an additional 1,500,000 restricted common shares of stock from recent acquisitions. See Note 2. Derivative LiabilitiesForeign Currency Translation
The Company records a debt discount relatedfunctional currency of the Company’s subsidiaries in Canada is the Canadian Dollar. The subsidiaries’ assets and liabilities have been translated to U.S. dollars using exchange rates of 0.711187 and 0.771486 in effect at the issuancebalance sheet dates of convertible debts thatMarch 31, 2020 and December 31, 2019, respectively. Unaudited condensed consolidated statements of operations amounts have conversion features at adjustable rates. The debt discountbeen translated using the annual weighted average exchange rates of 0.744205 for the convertible instruments is recognizedthree months ended March 31, 2020 and measured by allocating a portion of0.752067 for the proceedsthree months ended March 31, 2019. Resulting gains or losses from translating foreign currency financial statements are recorded as an increase in additional paid-in capital and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion features. The debt discount will be accreted by recording additional non-cashother comprehensive income (loss). Foreign currency transaction gains and losses relatedresulting from exchange rate fluctuations on transactions denominated in a currency other than the local currency are included in other income (expense). Foreign currency transaction gains recognized for the three-month periods ended March 31, 2020 and 2019 were $0 and $5,366, respectively. Fair Value of Financial Instruments Fair value of certain of the Company’s financial instruments including cash, prepaid expenses, accounts payable, accrued expenses, notes payable, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with ASC 820, “Fair Value Measurements and Disclosure” defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value investments. Fair value, as defined in ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise. The fair value of a liability should reflect the risk of non-performance, which includes, among other things, the Company’s credit risk. Valuation techniques are generally classified into three categories: the market approach; the income approach; and the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows: Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the changefair values. Fair value measurements are required to be disclosed by the Level within the fair value hierarchy in which the fair market values of derivative liabilities over the lifevalue measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in Level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the convertible notes.beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings, and a description of where those gains or losses included in earning are reported in the statement of income. Recently IssuedAdopted Accounting Pronouncements From timeIn June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) — Measurement of Credit Losses on Financial Instruments (ASU 2016-13). ASU 2016-13 requires entities to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies that are adopted by the Company as of the specifiedestablish an allowance for credit losses for most financial assets. Prior US GAAP was based on an incurred loss methodology for recognizing credit losses on financial assets measured at amortized cost and available-for sale debt securities. The update is effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective willfor fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 31, 2018. The amendments in this ASU did not have a material impact on our condensed consolidated financial position or results of operations upon adoption.statements.
Note 4 - Related Party TransactionsIn August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (ASC 820) — Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 removes certain disclosures, modifies certain disclosures and adds additional disclosures. ASU 2018-13 is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2019. Early adoption is permitted. The amendments in this ASU did not have a material impact on our condensed consolidated financial statements.
Recent Accounting Pronouncements No salariesIn December 2019, the FASB issued ASU 2019-12, Income Taxes (ASC 740) — Simplifying the Accounting for Income Taxes. ASU 2019-12 which modifies ASC 740 to simplify the accounting for income taxes. The ASU removes certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocation and calculating income taxes in interim periods. The ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. ASU 2019-12 is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2020. We have not yet completed the full assessment of the impact on our condensed consolidated financial statements or related disclosures.
In March 2020, The FASB issued ASU 2020-03, Codification Improvements to Financial Instruments – Issue 4: Cross-Reference to Line of-Credit or Revolving-Debt Arrangements Guidance in Subtopic 470-50. Stakeholders the ASU requests that paragraphs 470-50-40-17 through 40-18, which describe the accounting for fees between debtor and creditor and third-party costs directly related to exchanges or modifications of debt instruments, reference paragraph 470-50-40-21 for line-of-credit or revolving-debt arrangements. We have not yet completed the full assessment of the impact on our condensed consolidated financial statements or related disclosures. Note 2–Acquisitions Acquisition of 1922861 Ontario Inc. On April 12, 2018, the Company entered into and closed the transactions contemplated by the definitive asset purchase agreement and plan of re-organization by and among the Company, 1922861 Ontario Inc. a corporation organized under the laws of Ontario (“1922861 Ontario Inc.”), the stockholders of 1922861 Ontario Inc. and other parties signatory thereto to acquire all the operating assets of 1922861 Ontario Inc. for 500,000 restricted common shares of DLT Resolution valued at $212,520, and a payment of CAD $19,200 to 1922861 Ontario’s supplier. On September 21, 2018 the 1922861 Ontario Inc. acquisition reached the first milestone and received another 500,000 restricted commons shares of DLT Resolution valued at $205,295. The acquisition is considered a business combination for accounting purposes under ASC 805, and resulted in the integration of 1922861 Ontario Inc.’s operating assets and processes into the Company’s Canadian subsidiary DLT Resolution Corp. In addition to the consideration on closing, an additional 500,000 restricted shares of Company Common Stock may potentially be issued upon the acquired base generating CAD $500,000 in cumulated gross sales with a 10% pre-tax profit. The Company has allotted 24 months to achieve this milestone. There is full acceleration to allow for full vesting as quickly as the cumulative sales milestones are reached. The Company applied the acquisition method to the business combination and valued each of the assets acquired (cash, accounts receivable, equipment, customer relationships, software, domain names and non-compete agreements) and liabilities assumed (accounts payable and related party payable) at fair value as of the acquisition date. The carrying values of cash, accounts receivable, accounts payable and related party payable were paiddeemed to directors or executives duringbe fair value as of the periods ended September 30, 2017 or 2016.acquisition date. The Company determined the fair value of the equipment to be historical net book value. The preliminary allocation of the purchase price was based on estimates of the fair value of the assets and liabilities assumed based on provisional amounts. However, the allocation of excess purchase and the amounts allocated to intangible assets are now as per valuation of assets and liabilities performed by independent valuer. Under the purchase agreement, the Company issued 1,000,000 shares of Common Stock valued at $417,815 and committed to issue an additional 500,000 shares of Common Stock at certain milestones, which was determined to have a fair value of $685,000 with mark to market pricing of DLT stock price as of December 31, 2019 and March 31, 2020 using its $1.37 closing price as of both dates. The obligation to issue the 500,000 shares of Company Common Stock is shown as an “other long-term liabilities” on the face of the balance sheet and was valued at $685,000 as of March 31, 2020 and December 31, 2019, respectively. The following table shows the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition: ASSETS ACQUIRED | | | | Accounts receivable | | $ | 18,663 | | Customer list | | | 103,255 | | Developed technology | | | 321,679 | | Domain and trade name | | | 3,971 | | Non-compete | | | 37,330 | | Goodwill | | | 169,896 | | TOTAL ASSETS ACQUIRED | | $ | 654,794 | | | | | | | LIABILITIES ASSUMED | | | | | Accounts payable | | | 22,197 | | HST payable | | | 2,147 | | TOTAL LIABILITIES ASSUMED | | | 24,344 | | | | | | | NET ASSETS ACQUIRED | | $ | 630,450 | |
Acquisition of Union Strategies Inc. On January 31, 2017,30, 2020, the Company entered into a mutual releasetransactions contemplated by the definitive share for share exchange agreement with a related party with which there was an outstanding convertible noteand plan of $2,634re-organization (the “Purchase Agreement”) by and among the Company, Union Strategies. Inc. (“USI”), the stockholders of USI and other parties signatory thereto to acquire all the issued and outstanding accrued interestcapital stock of $1,923.USI for 1,500,000 shares of the Company’s restricted Common Stock (the “Closing Shares”). The agreement forgaveacquisition resulted in USI becoming a wholly-owned subsidiary of the outstanding payablesCompany. In the event that USI’s gross revenue for 2020 exceeds CAD $3,100,000 and they were writtenit generates a minimum $75,000 in EBITDA (the “Performance Targets”), the Company agreed to $0 againstissue an additional paid in capital1,000,000 shares of restricted Company Common Stock (“the Contingent Shares”) as additional purchase price consideration, which the Company estimates is probable that the Performance Targets will be achieved. Based on the date$1.60 closing share price of the agreement.Company’s Common Stock on January 30, 2020, the Closing Shares are valued at $2,400,000 and the Contingent Shares are valued at $1,600,000, for a total purchase price consideration of $4,000,000. DuringThe Company applied the nineacquisition method to the business combination and valued each of the assets acquired and liabilities assumed at fair value as of the acquisition date. The carrying values of accounts receivable, property and equipment, right to use asset, accounts payable, HST payable, accrued liabilities and lease obligation were deemed to be fair value as of the acquisition date. The preliminary allocation of the purchase price is based on estimates of the fair value of the assets and liabilities assumed based on provisional amounts. However, the estimates of the fair value of the assets acquired and liabilities assumed are subject to revision based on the results of their valuation performed by an independent valuer. The obligation to issue the Contingent Shares is subject mark to market pricing of DLT stock price and is included in “other long-term liabilities” on the face of the balance sheet and valued at $1,370,000 based on the $1.37 closing share price of DLT Common Stock on March 31, 2020.
The following table shows the estimated fair values of USI’s assets acquired and liabilities assumed at the January 30, 2020 date of acquisition: ASSETS ACQUIRED | | | | Accounts receivable, net | | $ | 163,138 | | Property and equipment, net | | | 91,506 | | Right to use asset, net | | | 14,001 | | Customer list | | | 2,073,780 | | Developed technology | | | 2,073,740 | | TOTAL ASSETS ACQUIRED | | $ | 4,416,126 | | | | | | | LIABILITIES ASSUMED | | | | | Accounts payable, HST payable and accrued liabilities | | | 402,582 | | Lease obligation | | | 13,544 | | TOTAL LIABILITIES ASSUMED | | | 416,126 | | | | | | | NET ASSETS ACQUIRED | | $ | 4,000,000 | |
Pro Forma The following table presents the unaudited pro forma results of the Company for the years ended December 31, 2019 and 2018 as if the acquisitions of USI and the combined 1922861 Ontario Inc. and DLT Resolution Corp. occurred on January 1, 2018. The pro forma results include estimates and assumptions which management believes are necessary. However, pro forma results do not include an anticipated cost savings or their effects of the planned integration of USI and 1922861 Ontario Inc. and are not necessarily indicative of the result that would have occurred if the business combination had been in effect on the dates indicated, or which may result in the future. The unaudited pro forma revenue and net loss for USI was approximately $2,730,000 and $175,000, respectively, for 2019. The unaudited pro forma revenue and net income for USI was approximately $2,700,000 and $88,000, respectively, for 2018. The unaudited pro forma revenue and net loss for the combined 1922861 Ontario Inc. and DLT Resolution Corp. was approximately $953,000 and $374,000, respectively, for the year ended December 31, 2018. The pro forma information includes adjustments for the amortization of intangible assets. | | Year ended December 31, | | | | 2019 | | | 2018 | | | | (unaudited) | | | (unaudited) | | | | | | | | | Revenue | | $ | 3,193,000 | | | $ | 3,653,000 | | Net loss | | | (1,730,000 | ) | | | (802,000 | ) |
USI and 1922861 Ontario Inc. did not have any material, nonrecurring pro forma adjustments directly attributable to the business combination included in the reported pro forma revenue and net losses. Note 3 – Goodwill and Intangible Assets Due to a sustained decline in the market capitalization of our common stock during the first quarter of 2020, we performed an interim goodwill impairment test. Management considered that, along with other possible factors affecting the assessment of the Company’s reporting unit for the purposes of performing a goodwill impairment assessment, including management assumptions about expected future revenue forecasts and discount rates, changes in the overall economy, trends in the stock price, estimated control premium, other operating conditions, and the effect of changes in estimates and assumptions that could materially affect the determination of fair value and goodwill. As a result of the significant decline in the current market capitalization despite any of the other positive factors contemplated and relatively little change in our ongoing business operations, the outcome of this goodwill impairment test resulted in a charge for the impairment of goodwill of $159,187 recorded in the unaudited condensed consolidated financial statements for the three months ended September 30, 2017,March 31, 2020. We amortize identifiable intangible assets on a related party paid $6,419straight-line basis over their estimated useful lives. As of expenses, $3,426 of outstanding payables on behalf of the company and $100 to repurchase treasury stock on behalf of the Company. The advances are due on demand and are included in current liabilities as a result. There was $49,544 and $39,599 due to related parties as of September 30, 2017March 31, 2020 and December 31, 2016.2019, identifiable intangibles were as follows: | | March 31, 2020 | | | December 31, 2019 | | | | | | | | | Developed technology | | $ | 2,237,296 | | | $ | 312,452 | | Customer relationships | | | 2,041,719 | | | | 100,293 | | Website | | | 119,000 | | | | 119,000 | | Domain and trade name | | | 3,556 | | | | 3,857 | | Non-compete | | | 33,426 | | | | 36,260 | | Accumulated amortization | | | (292,588 | ) | | | (195,402 | ) | Total intangible assets, net | | $ | 4,142,409 | | | $ | 376,460 | |
Expected future amortization expense related to identifiable intangibles based on our carrying amount as of March 31, 2020 for the following five years is as follows (in thousands): For the Twelve Months ended March 31, | | | | 2021 | | $ | 568,045 | | 2022 | | | 542,228 | | 2023 | | | 542,228 | | 2024 | | | 542,228 | | 2025 | | | 486,740 | | Thereafter | | | 1,460,940 | | | | $ | 4,142,409 | |
Note 4 – Note Payable On August 1, 2017, the Company entered intoissued a $10,000non-interest bearing $5,000 note payable with a related party to purchase 3,000,000 common shares as treasury stock. The note requires payments of $5,000due on July 1, 2019 $2,500 on July 1,to a third party in exchange for Company Common Stock held by the third party. As of March 31, 2020, and $2,500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum. There was $10,000 of principal and accrued interest of $49 due as of September 30, 2017.the note is unpaid. HEMCARE HEALTH SERVICES INC.
Notes to Unaudited Financial Statements
September 30, 2017
Note 5 – Other Long-term Liabilities Other long-term liabilities consist of the Company’s obligations to issue shares of its Common Stock pursuant to recent acquisitions. See Note 2. As of March 31, 2020, total other long-term liabilities $1,905,280 consisted of $631,461 for shares issuable for the Acquisition of 1922861 Ontario Inc. and $1,273,819 for the shares issuable for the acquisition of USI. As of December 31, 2019, total other long-term liabilities consisted of $685,000 for shares issuable for the Acquisition of 1922861 Ontario Inc. The liabilities are subject to mark to market accounting based on the market price of DLT shares of Common Stock and will be extinguished once the shares are issued. Note 6 – Stockholders’ Equity Common Stock On January 13, 2020, the Company issued 31,250 shares of restricted Company Common Stock to a third party individual in a stock subscription agreement for $25,000 in cash. The Company issued 1,500,000 shares of restricted Common Stock pursuant to the Purchase Agreement to acquire USI. See Note 2. Series A Convertible Preferred Stock The Company is authorized to issue up to 5,000,000 shares of Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock can be converted to common shares at the option of the holder at a rate equal toof $0.10 per share. During the nine months ended September 30, 2017, the Company issued 25,000 shares of Series A Convertible Preferred Stock in exchange for 2,417,000 shares of common stock.
There were 25,000 and 0no shares of series A convertible preferred stock issued and outstanding as of September 30, 2017March 31, 2020 and December 31, 2016. Additionally,2019. Series B Convertible Preferred Stock The Company is authorized to issue 500,000 shares of Series B Convertible Preferred Stock. The Series B Convertible Preferred Stock can be converted to common shares at the option of the holder at a rate of $0.20 per share. There were 64,000 shares of series B convertible preferred stock issued and outstanding as of March 31, 2020 and December 31, 2019. Note 7 - Related Party Transactions No compensation was incurred for the services of the Company’s directors or executives during the periods ended March 31, 2020 and 2019. As of March 31, 2020 and December 31, 2019, the Company had accrued dividendsoutstanding amounts payable to a related party payables of $20,858 and $20,880. The obligations are unsecured, non-interest bearing, due on series A convertible preferred stock totaling $25,448 at September 30, 2017demand and payable in Canadian dollars, with the change in the liability from December 31, 2016. Common Stock
On2019 to March 2, 2015,31, 2020 attributable to the Company effected a 1:50 reverse stock split. The effects ofchange in the reverse split are shown retroactively in these financial statements.exchange rate for U.S. and Canadian dollars.
The authorized common stock of the Company consists of 275,000,000 shares and carrieshas a par value of $0.001. During the year ended December 31, 2014, the Company bought back 380,000 post-split shares of common stock into treasury from a former officer for $100. The shares are being carried as treasury shares as reflected on the balance sheet. During the year ended December 31, 2016, the Company issued 131,170,000 common shares for the conversion of 131,170 shares of Series A Preferred Stock. There was no gain or loss on this conversion
During the nine months ended September 30, 2017, the Company entered into agreements with various individuals and entitiesnote payable to cancel a total of 71,140,000 shares of its common stock; entered into $10,000 of related party notes payable for the purchase of 3,000,000 shares of common stock; entered into $85,000 of notes payable for the purchase of 65,670,000 shares of common stock; purchased 20,000,000 common shares through an advance from a related party and 12,500,000 common shares in exchange for $250,000 of outstanding note principal.
There were 212,275,211 and 273,332,211 common shares issued and 123,225,211 and 272,952,211 shares outstanding as of September 30, 2017 and December 31, 2016, respectively.
Note 6 – Notes Payable
During the year ended December 31, 2015, the Company entered into a note payable with an unrelated party as a settlement for payment of consulting services provided valued at $350,000.services. The note carries interest of 9% compounded annually and is due on November 19, 2016. During the year endeddemand. As of March 31, 2020 and December 31, 2016, the Company issued 50,000 shares2019, $81,500 of series A convertible preferred stock as repayment of $31,500principal and $36,034 and $34,190 of accrued interest and $18,500 of outstanding principal. During the nine months ended September 30, 2017, the Company issued 12,500,000 shares of common stock in exchange for $250,000 of principal and extended the maturity date to January 26, 2018. There was $81,500 and $331,500 of principal and $17,696 and $10,299 of accrued interest due, as of September 30, 2017 and December 31, 2016. Accrued interest payable is included in “accounts payable and accrued liabilities” on the balance sheet.respectively.
Note 8 – Concentrations During the nine monthsthree-month periods ended September 30, 2017,March 31, 2020 and 2019, no single customer accounted for more than 10% of our total revenue for the Company entered into an agreement with a noteholder to forgive a $600 outstanding note payable. The Company wrote the balance to $0 as a dischargerespective periods. As of indebtedness on the statements of operations. There was $0 and $600 outstanding as of September 30, 2017March 31, 2020 and December 31, 2016.2019, no single customer had an outstanding accounts receivable balance that exceeded 10% of our total accounts receivable at that time. On August 1, 2017, the Company entered into a note payable for $75,000 to purchase 52,500,000 shares of common stock. The note requires payments of $25,000 on July 1, 2019, $25,000 on July 1, 2020 and $25,0500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum. There was $75,000 of principal and accrued interest of $370 due as of September 30, 2017.
HEMCARE HEALTH SERVICES INC.
Notes to Unaudited Financial Statements
September 30, 2017
Note 6 – Notes Payable (continued)
On August 1, 2017, the Company entered into a note payable for $10,000 to purchase 13,170,000 shares of common stock. The note requires payments of $5,000 on July 1, 2019, $2,500 on July 1, 2020 and $2,500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum. There was $10,000 of principal and accrued interest of $49 due as of September 30, 2017.
Note 7 – Convertible Notes Payable
During the nine months ended September 30, 2017, the Company entered into an agreement with a convertible noteholder for the extinguishment the outstanding principal of the convertible note of $24,383 and interest of $1,923 for a total $26,306. There was $0 and $23,784 net of discounts outstanding at September 30, 2017 and December 31, 2016.
On May 22, 2017, the Company entered into a convertible note payable for $4,900 which was paid to third parties on our behalf resulting in net cash proceeds to the Company of $0. The note carries interest at a rate of 10% per annum and is due on August 20, 2017. The note and accrued interest is convertible into common stock of the Company at a rate equal to a 50% discount from the stock price on the date of conversion if converted within the first 90 days and the lesser of a 50% discount from the stock price on the date of conversion and $0.01 if converted after 90 days. There was $4,900 of principal, debt discounts of $0 and accrued interest totaling $994 outstanding as of September 30, 2017.
Note 8 – Derivative Liability
As discussed in Note 3, on a recurring basis, we measure certain financial assets and liabilities based upon the fair value hierarchy. The following table presents information about the Company’s liabilities measured at fair value as of September 30, 2017 and December 31, 2016:
| | Level 1 | | | Level 2 | | | Level 3 | | | Fair Value at September 30, 2017 | | Liabilities | | | | | | | | | | | | | Derivative Liability | | $ | - | | | $ | 68,793 | | | $ | - | | | $ | 68,793 | | | | | | | | | | | | | | | | | Level 1 | | | Level 2 | | | Level 3 | | | Fair Value at December 31, 2016 | | Liabilities | | | | | | | | | | | | | | | | | Derivative Liability | | $ | - | | | $ | - | | | $ | - | | | $ | - | |
As of September 30, 2017, the Company had a $68,793 derivative liability balance on the balance sheet and recorded a loss from derivative liability fair value adjustment of $63,886 and $63,445 during the three and nine months ended September 30, 2017. The Company assessed its outstanding convertible notes payable as summarized in Note 7 – Convertible Notes Payable and determined certain convertible notes payable with variable conversion features contain embedded derivatives and are therefore accounted for at fair value under ASC 920, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments.
Utilizing Level 2 Inputs, the Company recorded fair market value adjustments related to convertible notes payable for the nine months ended September 30, 2017 and 2016 of $63,445 and $0, respectively. The fair market value adjustments were calculated utilizing the Black-Sholes method using the following assumptions: risk free rates of 1.20%, dividend yield of 0%, expected lives of 0.50 years, and volatility of 189%.
HEMCARE HEALTH SERVICES INC.
Notes to Unaudited Financial Statements
September 30, 2017
Note 8 – Derivative Liability (continued)
A summary of the activity of the derivative liability is shown below:
Balance at December 31, 2016 | | $ | - | | Derivative liabilities recorded | | | 5,348 | | Change due to note conversion | | | - | | Fair value adjustment | | | 63,445 | | Balance at September 30, 2017 | | $ | 68,793 | |
Note 9 – Commitments and Contingencies DuringLitigation
On March 29, 2019, DLT Resolution Corp. and DLT Resolution Inc. was served with a Statement of Claimants 300-306 Town Centre Boulevard Limited Partnership/Court File No. CV-19-00617228-000 (Toronto) for unpaid rent and lost revenue related to the yearpremises. In this action, the Plaintiff has claimed damages against the Defendants DLT Resolution Corp. and DLT Resolution Inc. in the amount of $567,385.13 for an alleged breach of lease. The Plaintiff has claimed damages against the Defendant DLT Resolution Inc. in the amount of $567,385.13 for allegedly wrongfully inducing a breach of lease and tortious interference with contractual relations. The Plaintiff has further claimed damages against the Defendant DLT Resolution Inc. in the amount of $567,385.13 for allegedly oppressive conduct under the Ontario Business Corporations Act. The Plaintiff has further claimed compensation for its legal costs and for pre-judgment interest. The Company filed a statement of Defense citing, amongst other things, that it has never entered into any agreement with the landlord, nor guaranteed any such liability. The Defendants DLT Resolution Corp. and DLT Resolution Inc. intend to contest the claim vigorously. There is no intention to make a settlement offer nor have instructions been received to make a settlement offer at this juncture. Since the statement of defense was delivered on 16 May 2019, the Company had no further communication from counsel for the Plaintiff nor have any steps been taken to move the litigation forward. Although there can be no assurance of the Company’s ability to dismiss the claim, management feels the claim is without merit and is confident it will receive a ruling in its favor. Leases Commitment Under Topic 842, operating lease expense is generally recognized evenly over the term of the lease. USI has an operating lease for its Edmonton, Canada facility that started in March 2019 and terminates in February 2022. There was no sublease rental income for the three-month periods ended March 31, 2020 and 2019. USI paid approximately $2,222 against the Lease obligation in the three months ended March 31, 2020. USI’s lease agreement does not provide an implicit borrowing rate; therefore, an internal incremental borrowing rate is determined based on information available at lease commencement date for purposes of determining the present value of lease payments. ROU lease asset and lease liability for the operating lease is recorded in the balance sheet as follows: | | As of | | | | March 31, 2020 | | Operating lease - right of use asset | | $ | 11,642 | | | | | | | Lease obligations — operating leases, current portion | | $ | 6,023 | | Lease obligations — operating leases, net of current portion | | | 5,128 | | Total lease liability | | $ | 11,151 | | | | | | | Weighted average remaining lease term (in years) | | | 1.9 | | Weighted average discount rate | | | 7.75 | % |
Future lease payments included in the measurement of lease liabilities on the unaudited balance sheet as of March 31, 2020, for the following five fiscal years and thereafter were as follows: | | For the year ending | | | | December 31, | | | | | | 2020 | | $ | 5,121 | | 2021 | | | 6,827 | | 2022 | | | 1,138 | | Total future minimum lease payments | | | 13,086 | | Present value adjustment | | | 1,935 | | Total | | $ | 11,151 | |
Other Commitments As permitted under Canadian Corporations Business Act, USI agrees to indemnify officers and directors for certain events or occurrences while the officer or director is, or was, serving at USI’s request in this capacity. The term of the indemnification period is indefinite. There is no limit on the amount of future payments USI could be required to make under these indemnification agreements; however, USI maintains insurance policy coverage that may enable USI to recover a portion of any amounts paid. As a result of USI’s insurance policy coverage, management believes the estimated fair value of these indemnifications is minimal. Accordingly, USI did not record any indemnification liabilities as of March 31, 2020 and December 31, 2015, the Company issued a total of 100,000 shares of series A convertible preferred stock in exchange for a prepayment of royalties and 40 complete Ultroid systems. Additionally, as discussed in Note 6, the Company entered into two separate convertible notes payable with an unrelated party. These transactions were not approved by unanimous board consent through the Company’s normal approval procedures. As such, the Company may challenge the validity of these agreements after additional review of the relevant details.2019. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation.Shareholders’ EquityGeneral Plan of OperationsSPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS
The Company was organized January 17, 2007 (Date of Inception) underThis Quarterly Report on Form 10-Q contains forward-looking statements that have been made pursuant to the lawsprovisions of the StatePrivate Securities Litigation Reform Act of Nevada,1995. These forward-looking statements are based on current expectations, estimates, and projections about DLT Resolutions’ industry, management’s beliefs, and certain assumptions made by management. Forward-looking statements include our expectations regarding product, services, and maintenance revenue, annual savings associated with the organizational changes effected in prior years, and short- and long-term cash needs. In some cases, words such as DBL Senior Care, Inc.“anticipates,” “expects,” “intends,” “plans,” “believes,” “estimates,” variations of these words, and subsequently changed its namesimilar expressions are intended to HemCare Health Services Inc. on March 2, 2015.
Under previous management,identify forward-looking statements. In addition, statements about the initial businesspotential effects of the Company was to provide personal care services to elderly, physically disabled or other home-bound individuals suffering infirmity. During the year ended December 31, 2009, the board of directors changed the Company's focus toward the manufacture and sale of fire retardant products. The Company then changed its focus to the licensing of certain technologies related to rare earth minerals then to having the exclusive rights to the use of Optimum Performance (a proprietary formulation of a highly potent all-in-one daily feed supplement for the Horse industry. The Company while still keeping within the health and wellness industries, narrowed its focus to hemorrhoid medical procedures and entered into a license agreement to open hemorrhoid treatment centers and promote the Ultroid Hemorrhoid System globally during the year ended December 31, 2015 which was ceased in late 2016 due to numerous issues and concerns with the Licensor’s business, technology and principals. With the business focus potentially shifting the board asked for the former chief executive officer's resignation and Mr. John Wilkes returned to his former role as chief executive. Under Mr. Wilkes leadership, the company has been developing a new business strategy and objective still within the health care space but now focusingCOVID-19 pandemic on the information Exchange sector.
To this end management working together with significant shareholders, have been developing strategiesCompany’s businesses, results of operations and alliancesfinancial condition may constitute forward-looking statements. The statements are not guarantees of future performance and are subject to fulfil this objective. At the close of the fiscal year management begancertain risks, uncertainties, and assumptions that are difficult to develop a platformpredict; therefore, actual results may differ materially from those expressed or forecasted in any forward-looking statements. Risks and portal for the Information Exchange with aim to completion and market launch in the 2nd quarter of 2017.
During the second quarter of 2017, the Company rolled out a soft launch of is Health Information Exchange portal, www.RecordsBank.org.
RecordsBank.org a Centralized System for Patients, Lawyers & Insurers to Retrieve and Access Medical Records. The centralized system and portal is a cloud-based PIPEDA & HIPAA compliant network of Providers and Record Requestors. Utilizing a secure platform, providers will be able to securely exchange records electronically with third-party requestors. Health care providers with proper authorization can also share records with each other.
Limited Operating History; Need for Additional Capital
There is no historical financial information about us upon which to base an evaluationuncertainties of our performance. Our assets and business have not yet generated substantial or recurring revenues. We cannot guarantee we will be successfulinclude those set forth in our business operations. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources and possible cost overruns due to price and cost increases in services.
We will require additional financing to cover costs that we expect to incur over the next twelve months. We believe that debt financing will not be an alternative for funding our operations as we do not have tangible assets to secure any debt financing. We anticipate that additional funding will be in the form of equity financing from the sale of our common stock or other securities. However, we cannot provide any assurance that we will be able to raise sufficient funding from the sale of our common stock to fund our plan of operations. In the absence of such financing, we will not be able to continue and our business plan will fail.
Results of Operations
Revenues
Revenues during the three and nine months ended September 30, 2017 and 2016 were $0. The timing of generating revenues from the execution of the Company’s current business plan is presently undeterminable.
Operating Expenses
Total operating expenses were $3,700 and $2,390 during the three months ended September 30, 2017 and 2016. The increase in operating expenses relate to the Company incurring additional general office expenses during the current period as it executes its business plan.
Total operating expenses were $21,298 and $25,436 during the nine months ended September 30, 2017 and 2016. The decrease in operating expenses relate to the Company having incurred additional professional fees during the period ended September 30, 2016 related to the timing of filing its audited financial statementsAnnual Report on Form 10-K for the year ended December 31, 2016.2019, as filed with the SEC on April 30, 2020, under “Item 1A. Risk Factors” as well as additional risks described in this Form 10-Q. Unless required by law, we undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. However, readers should carefully review the risk factors set forth in other reports or documents we file from time to time with the Securities and Exchange Commission, particularly the Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K.
Overview DLT Resolution Inc. (“DLT, the “Company”, “we” and “our”) operates in three high-tech industry segments: Blockchain Applications; Telecommunications; and Data Services which includes Image Capture, Data Collection, Data Phone Center Services, and Payment Processing. The Company offers secure data management, Information Technology (IT) and other telecommunications services in Canada and the United States. The Company operates a Health Information Exchange providing the ability to request and retrieve medical information and records while meeting all of today’s Security & Compliance demands for HIPAA, PIPEDA and PHIPA. Through our acquisition of Union Strategies, Inc. (“USI”), the Company operates a business focused on designing, installing and maintaining telephony, data, video, storage, and LAN/WAN networks. USI’s clients encompass K-12 and higher education institutions, trades industry organizations, and local government entities having memberships ranging from 100 to 10,000 people that utilize products and services that USI provides by deploying a variety of technologies to keep client networks up and running efficiently. Recent Developments On January 30, 2020, the Company acquired all the issued and outstanding capital stock of USI for 1,500,000 shares of the Company’s restricted Common Stock with the potential issuance of an additional 1,000,000 shares should USI achieve financial performance targets (See Note 2). The acquisition, valued at $4,000,000 resulted in USI becoming a wholly owned subsidiary of the Company. USI was organized on October 24, 2011 under the Ontario Business Corporations Act of 1990 and is located in Woodbridge, Ontario, Canada. USI is focused on designing, installing and maintaining telephony, data, video, storage, and LAN/WAN networks. USI has clients encompassing K-12 and higher education institutions, trades industry organizations, and local government entities having memberships ranging from 100 to 10,000 people that utilize products and services that USI provides by deploying a variety of technologies to keep client networks up and running efficiently. Results of Operations Revenues Revenues for the three months ended March 31, 2020 and 2019 were $428,347 and $122,009, respectively. The increase resulted primarily from the inclusion of USI’s $325,571 in revenue from the acquisition on January 30, 2020 to March 31, 2020. Cost of Revenue Cost of revenue for the three months ended March 31, 2020 and 2019 were $238,686 and $33,674, respectively. The increase resulted primarily from the inclusion of USI’s $199,776 in cost of revenue from the acquisition on January 30, 2020 to March 31, 2020. General and Administrative General and administrative expense, excluding professional fees, was $196,245 and $59,354 for the three months ended March 31, 2020 and 2019, respectively. The increase resulted primarily from the inclusion of USI’s $85,382 in general and administrative expense from the acquisition on January 30, 2020 to March 31, 2020. Professional Fees Professional fees were $40,439 and $32,571 for the three months ended March 31, 2020 and 2019, respectively. The increase resulted primarily from the inclusion of USI’s $9,450 in professional fees from the acquisition on January 30, 2020 to March 31, 2020. Depreciation and Amortization Depreciation and amortization expense was $115,268 and $25,655 for the three months ended March 31, 2020 and 2019, respectively. The increase resulted primarily from the inclusion of USI’s $89,777 in depreciation and amortization expense from the acquisition on January 30, 2020 to March 31, 2020 that relates to USI’s intangible assets and property, plant and equipment. Goodwill Impairment Loss Due to a sustained decline in the market capitalization of our common stock during the first quarter of 2020, we performed an interim goodwill impairment test. Management considered that, along with other possible factors affecting the assessment of the Company’s reporting unit for the purposes of performing a goodwill impairment assessment, including management assumptions about expected future revenue forecasts and discount rates, changes in the overall economy, trends in the stock price, estimated control premium, other operating conditions, and the effect of changes in estimates and assumptions that could materially affect the determination of fair value and goodwill. As a result of the significant decline in the current market capitalization despite any of the other positive factors contemplated and relatively little change in our ongoing business operations, the outcome of this goodwill impairment test resulted in a charge for the impairment of goodwill of $159,187 in the three months ended March 31, 2020. Other Income (Loss)Expense The Company had net other expensesexpense of $69,104 during$7,424 and $854,796 for the three months ended September 30, 2017 compared to net other expense of $7,994 during the three months ended September 30, 2016.March 31, 2020 and 2019, respectively. The decrease in net other expenselarge change is the result of fewer debt discounts on convertible notes payable being recognized as interest expense during the three months ended September 30, 2017 when compareddue to the same period2019 disposition of the investment in 2016A.J.D. Data Services and an increasethe 2019 loss from a change in the loss recognized on the measurementfair market liability of a derivative liabilities of $63,886 during the three months ended September 30, 2017 when compared to the three months ended September 30, 2016.liability that existed at that time. Net Loss The Company had net other losses of $51,347 during the nine months ended September 30, 2017 compared to net other expense of $44,525 during the nine months ended September 30, 2016. The increase in net other expense is the result of losses recognized on the measurement of derivative liabilities that existing during the nine months ended September 30, 2017 that did not exist in the prior period, debt forgiveness totaling $26,306 during the nine months ended September 30, 2017 that did not exist in the prior period and the amortization of debt discounts associated with convertible notes payable there were outstanding during the nine months ended September 30, 2016 and not during the nine months ended September 30, 2017. Net Income (Loss)
The Company hada net loss of $72,804 during$328,902 and $884,041 for the three months ended September 30, 2017 compared to a net loss of $10,384 during the three months ended September 30, 2016.March 31, 2020 and 2019. The increasedecrease in net loss isin the current year primarily resulted from the decrease in other expense, which was partially offset by the inclusion of USI’s net result of timing of professional services, lossfollowing the acquisition on derivative liability measurements, forgiveness of outstanding debts and the amortization of debt discounts as discussed previously.January 30, 2020 through March 31, 2020.
| 15 | The Company had net loss of $72,645 during the nine months ended September 30, 2017 compared to a net loss of $69,961 during the nine months ended September 30, 2016. The increase in net loss is the result of timing of professional services, loss on derivative liability measurements, forgiveness of outstanding debts and the amortization of debt discounts as discussed previously.
| Table of Contents |
Liquidity and Capital Resources As of September 30, 2017March 31, 2020, we had $0total current assets of $171,396 and current liabilities of $656,256 creating a working capital deficit of $484,860. As of December 31, 2019, we had $13,140 of cash, total current assets of $0$47,771 and current liabilities of $336,848$267,553 creating a working capital deficit of $336,848. Current liabilities as of September 30, 2017 consisted of $7 of bank overdrafts, $106,656 of accounts payable and accrued liabilities, $49,544 of related party payables, $25,448 of dividends payable, notes payable of $81,500, a derivative liability of $68,793 and convertible notes payable net of discounts of $4,900. Cash Used in Operating Activities$219,782.
Net cash used in operating activities was $0$19,527 during the ninethree months ended September 30, 2017March 31, 2020 compared to $26,941 used$112,979 for the same period in 2016. The decrease in2019. Net cash used in operatinginvesting activities is from an increase in non-cash gains realized and a lesser change in working capitalwas $1,911 during the ninethree months ended September 30, 2017 whenMarch 31,, 2020 compared to $0 for the ninesame period in 2019. During the three months ended September 30, 2016.March 31, 2020, the Company generated $9,466 cash from financing activities. During the three months ended March 31, 2019, the Company generated $146,407 of cash from financing activities that was the proceeds of advances from related parties, net of repayments. Cash from Financing ActivitiesGoing Concern
We have funded our business to date primarily from loans from directors or other related parties. There are no assurances that we will be able to achieve further saleshad an accumulated deficit of our common stock or any other form of additional financing. If we are unable to achieve the financing necessary to continue our plan of operations, then we will not be able to continue our operations$4,653,230 and our business will fail. Going Concern
Through September 30, 2017, management has devoted most of its activities to developing a market for its products and services. We have yet to generate revenues from our planned business activities, have no cash on hand and have a working capital deficit of $336,848 which raises$219,782 as of December 31, 2019. These matters raise substantial doubt for the entity to be ableabout our ability to continue as a going concern.
Future Financing
We anticipate continuing to rely on equity sales Continuation of our common stockexistence depends upon our ability to obtain additional capital. Our plans in orderregards to continue to fund our business operations.this matter include raising additional equity financing and borrowing funds under a private credit facility and/or other credit sources. Issuances of additional shares will result in dilution todilute the ownership of our existing shareholders. There is no assurance that we will achieve any additional sales of our equity securities or arrange for debt or other financing to fund our planned operations.
Our unaudited condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern. This contemplates the realization of assets and the liquidation of liabilities in the normal course of business. Currently, we have limited cash, and an accumulated deficit of $4,653,230. These factors raise substantial doubt about our ability to continue as a going concern. We will be dependent upon the raising of additional capital through placement of our common stock in order to implement its business plan, or merge with an operating company. There can be no assurance that we will be successful in either situation in order to continue as a going concern. Our officers and directors have demonstrated a willingness to advance funds to us to be used to pay certain of our operating costs. Off-Balance Sheet Arrangements We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders. Lawsuits
To management’s knowledge there is no pending, or threatened lawsuit against the Company
Item 3. Quantitative and Qualitative Disclosures About Market Risk. As a smaller reporting company, we are not required to provide the information required by this item.Not applicable.
Item 4. Controls and Procedures. Disclosure Controls and Procedures We maintainManagement of DLT Resolution Inc. is responsible for maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) that are designed to ensure that information required to be disclosed by us in the reports we filethat the Company files or submitsubmits under the Securities Exchange Act of 1934 as amended,(the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’sSecurities and Exchange Commission’s rules and formsforms.
In addition, the disclosure controls and procedures must ensure that such information is accumulated and communicated to the Company’s management, including ourits Chief Executive Officer (as our chief executive officer and chief financial officer),Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. In designingfinancial and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily isother required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. As ofdisclosures. At the end of the period covered by this report, an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”)) was carried out under the supervision and with the participation of management, including our ChiefPrincipal Executive Officer, whoPrincipal Financial and Accounting Officer. Based on his evaluation of our disclosure controls and procedures, he concluded that during the period covered by this report, such disclosure controls and procedures were not effective to detect the inappropriate application of US GAAP standards. This was due to deficiencies that existed in the design or operation of our internal control over financial reporting that adversely affected our disclosure controls and that may be considered to be “material weaknesses.” The Company will continue to create and refine a structure in which critical accounting policies and estimates are identified, and together with other complex areas, are subject to multiple reviews by accounting personnel. In addition, the Company will enhance and test our year-end financial close process. Additionally, the Company’s management will increase its review of our disclosure controls and procedures. Finally, we plan to designate individuals responsible for identifying reportable developments. We believe these actions will remediate the material weakness by focusing additional attention and resources in our internal accounting functions. However, the material weakness will not be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. Changes in Internal Control over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; (iii) provide reasonable assurance that receipts and expenditures of company assets are made in accordance with management authorization; and (iv) provide reasonable assurance that unauthorized acquisition, use or disposition of company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because changes in conditions may occur or the degree of compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act, conducted an evaluation ofDecember 31, 2017. In assessing the effectiveness of our internal control over financial reporting as of December 31, 2018, our management used the design and operationcriteria set forth by the Committee of these disclosure controls and procedures.Sponsoring Organizations of the Treadway Commission (2013 framework). Based on this evaluationits assessment, management concluded that our internal control over financial reporting as of December 31, 2018 was not effective in the specific areas described in the “Disclosure Controls and subjectProcedures” section above and as specifically described in the paragraphs below. As of December 31, 2019, the Principal Executive Officer/Principal Financial Officer identified the following specific material weaknesses in the Company’s internal controls over its financial reporting processes: · | Policies and Procedures for the Financial Close and Reporting Process — Currently there are no policies or procedures that clearly define the roles in the financial close and reporting process. The various roles and responsibilities related to this process should be defined, documented, updated and communicated. Failure to have such policies and procedures in place amounts to a material weakness to the Company’s internal controls over its financial reporting processes. | | | · | Representative with Financial Expertise — For the year ending December 31, 2018, the Company did not have a representative with the requisite knowledge and expertise to review the financial statements and disclosures at a sufficient level to monitor the financial statements and disclosures of the Company. Failure to have a representative with such knowledge and expertise amounts to a material weakness to the Company’s internal controls over its financial reporting processes. | | | · | Adequacy of Accounting Systems at Meeting Company Needs — The accounting system in place at the time of the assessment lacks the ability to provide high quality financial statements from within the system, and there were no procedures in place or built into the system to ensure that all relevant information is secure, identified, captured, processed, and reported within the accounting system. Failure to have an adequate accounting system with procedures to ensure the information is secure and accurately recorded and reported amounts to a material weakness to the Company’s internal controls over its financial reporting processes. | | | · | Segregation of Duties — Management has identified a significant general lack of definition and segregation of duties throughout the financial reporting processes. Due to the pervasive nature of this issue, the lack of adequate definition and segregation of duties amounts to a material weakness to the Company’s internal controls over its financial reporting processes. |
In light of the foregoing, our Chief Executive Officer concluded thatonce we have the adequate funds, management plans to develop the following additional procedures to help address these controls are not effective considering the level and nature of the Company’s operations and the number and types of transactions concluded by the Company.material weaknesses: Changes in Internal Control Over Financial Reporting
· | The Company will create and refine a structure in which critical accounting policies and estimates are identified, and together with other complex areas, are subject to multiple reviews by accounting personnel. In addition, we plan to enhance and test our month-end and year-end financial close process. Additionally, our audit committee will increase its review of our disclosure controls and procedures. We also intend to develop and implement policies and procedures for the financial close and reporting process, such as identifying the roles, responsibilities, methodologies, and review/approval process. We believe these actions will remediate the material weaknesses by focusing additional attention and resources in our internal accounting functions. However, the material weaknesses will not be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. |
During the period covered by this report management of the Company was expanded to include more than one individual. As such, there were significantThere have been no changes in our internal controlscontrol over financial reporting that occurred during the period. For example, for the time being and until the operations of the company make this impractical all financial transactions involving the Company, including all payments and all agreed upon incurrences of liabilities, require a signature from,three months ended March 31, 2020 that have materially affected, or other approval from, the CEO or CFO of Hemcare Health Services. Notwithstanding these changes, as the company was previously a shell company owned and managed by one person, management has no reasonare reasonable likely to believe that thematerially affect, our internal controls in place at that time were insufficient. Furthermore, management believes that until the operations of the Company progress to the point where tight control impedes smooth operations, it will be appropriate and sufficient (from the perspective of internal controls over financial reporting) if approval of the CEO and CFO is required for transactions that are or are reasonably likely to require disclosure in the financial statements.reporting.
PART II - OTHER INFORMATION Item 1. Legal Proceedings. WeOn March 29, 2019, DLT Resolution Corp. and DLT Resolution Inc. was served with a Statement of Claimants 300-306 Town Centre Boulevard Limited Partnership/Court File No. CV-19-00617228-000 (Toronto) for unpaid rent and lost revenue related to the premises. In this action, the Plaintiff has claimed damages against the Defendants DLT Resolution Corp. and DLT Resolution Inc. in the amount of $567,385.13 for an alleged breach of lease. The Plaintiff has claimed damages against the Defendant DLT Resolution Inc. in the amount of $567,385.13 for allegedly wrongfully inducing a breach of lease and tortious interference with contractual relations. The Plaintiff has further claimed damages against the Defendant DLT Resolution Inc. in the amount of $567,385.13 for allegedly oppressive conduct under the Ontario Business Corporations Act. The Plaintiff has further claimed compensation for its legal costs and for pre-judgment interest. The Company filed a statement of Defense citing, amongst other things, that it has never entered into any agreement with the landlord, nor guaranteed any such liability. The Defendants DLT Resolution Corp. and DLT Resolution Inc. intend to contest the claim vigorously. There is no intention to make a settlement offer nor have instructions been received to make a settlement offer at this juncture. Since the statement of defense was delivered on 16 May 2019, the Company had no further communication from counsel for the Plaintiff nor have any steps been taken to move the litigation forward. Although there can be no assurance of the Company’s ability to dismiss the claim, management feels the claim is without merit and is confident it will receive a ruling in its favor. There are legal fees in the amount of $5,287.24 that is yet to be paid with regards to this settlement which have been accrued and are in the accounts payable as of December 31, 2019. The bill will be paid within the month.
Item 1. Risk Factors. A pandemic, epidemic, or outbreak of infectious disease such as the current coronavirus (COVID-19) pandemic could have an adverse effect on our business, operating results or financial condition. Our business could be adversely impacted by the effects of a pandemic, epidemic, or outbreak of an infectious disease, such as the recent and ongoing COVID-19 outbreak in various parts of the world in which we operate, which has now been declared a global pandemic by the World Health Organization. This outbreak could adversely impact our operations, the operations of our customers and the global economy. Disruptions to our business could include restrictions on our ability to travel and distribute our products, suspension or government-mandated shutdown of operations by us or our customers, or the delay of projects in impacted areas. Travel restrictions or operational problems where we or our customers operate may cause a reduction in the demand for our services. For example, the governor of both Nevada (where our corporate headquarters is located) and Canadian governmental bodies (where several of our executive officers are based) have issued stay-at-home orders which urge residents to work from home and mandate the closures of businesses that are considered non-essential. Any of these events could negatively impact our business, operating results or financial condition. The COVID-19 Pandemic is having an adverse effect on our business. The ongoing COVID-19 pandemic crisis has already caused several instances where meetings and other interactions relevant to our business progress have been postponed or delayed. Our customers are wireless carriers who have, in many instances, begun adopting policies that limit the accessibility of their campuses to external personnel. In addition, government-mandated stay-at-home orders have recently been issued in many of the jurisdictions where we or our customers do business, which will prevent us from conducting in-person meetings with customers while those orders are in effect. Although most of these government mandates are effective for limited periods of time, they may be extended indefinitely depending on ongoing developments related to COVID-19. At the time of this filing, this sporadic lack of access has resulted in only slight delays that are not presently a partyquantitatively detrimental to any legal proceedingsoperating results, but as the situation and toits response continue, this could change. If this current situation continues or extends, because of either our knowledge, no such proceedings are threatenedcustomers’ policies and practices or pending.government-mandated stay-at-home orders, restrictions on travel or gatherings of people, our results will be negatively impacted. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. None.
DescriptionOn January 13, 2020, the Company issued 31,250 shares of Registrant’s Securitiesrestricted Company Common Stock to be Registereda third party individual in a stock subscription agreement for $25,000 in cash.
The authorized capital stock of our Company consists of 275,000,000issued 1,500,000 shares of common stock, par value $0.001 per share,restricted Company Common Stock to the former shareholders of which there are currently 214,692,211USI in exchange for all of USI’s issued and 214,312,211 outstanding and 5,000,000common shares of series A convertible preferred stock authorized of which there are 0 shares issued and outstanding. All outstanding shares of common stock are of the same class and have equal rights and attributes. The holders of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders of the Company. All stockholders are entitled to share equally in dividends, if any, as may be declared from time to time by the sole director out of funds legally available. In the event of liquidation, the holders of common stock are entitled to share ratably in all assets remaining after payment of all liabilities. The stockholders do not have cumulative or preemptive rights.(see Note 2).
Item 3. Defaults Upon Senior Securities. None. Item 4. Submission of Matters to a Vote of Security Holders.Mine Safety Disclosures. None Item 5. Other Information. None. Item 6. Exhibits. The following exhibits are attached hereto: SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Hemcare Health Services Inc.
DLT Resolution, Inc. | | | | | | | | By: | /s/ John Wilkes | | By:
| /s/ John Wilkes | | | John Wilkes | | | John Wilkes | | | President and Chief Executive Officer | | | Chief Financial Officer, Secretary and Treasurer | | | (Principal Executive Officer) | | | (Principal Financial Officer) | | | | | | | | | November 20, 2017July 7, 2020
| | | November 20, 2017July 7, 2020
| | |
|